ViroCell Biologics, a company focused on cell and gene therapy contract development and manufacturing, has signed a five-year agreement with a leading U.S. cancer center for GMP viral vector manufacturing for clinical trials. The cancer center...
The acquisition of Valinor Pharma, LLC (Valinor) and its product Movantik (naloxegol) was announced by Grünenthal, a top company in pain management and related illnesses, with a total cost of around $250 million including royalty obligations...
RUSAN PHARMA PRIVATE LIMITED, a pharmaceutical company headquartered in India that focuses on addiction treatment and pain management, has just confirmed that its Active Pharmaceutical Ingredient (API) facility in Ankleshwar (Gujarat, India) has...
While India anticipates the Union Budget 2024, the pharmaceutical industry in India is looking forward to initiatives that will improve their expansion and reinforce India's standing as a global leader. At present, the pharmaceutical industry is...
The first generic raltegravir medications for treating adult and pediatric HIV patients weighing at least 40kg have been authorized by the UK Medicines and Healthcare products Regulatory Agency (MHRA). HIV is responsible for AIDS, which...
Renalys Pharma, Inc. reported the dosing of the initial participant in its phase III clinical trial of sparsentan for IgA nephropathy treatment in Japan. Renalys submitted an Investigational New Drug (IND) Application for sparsentan to the...
The UK Medicines and Healthcare products Regulatory Agency (MHRA) has given the green light for the medication vibegron (Obgemsa) to address symptoms of overactive bladder (OAB) syndrome in adult patients. Indications might consist of a sudden...
The increasing prevalence of neurological disorders is fueling market expansion, as there is a shift towards manufacturing radiopharmaceuticals utilizing cyclotron technology. Yet, challenges arise due to issues with preparing and distributing...
Miltenyi Biotec, a prominent provider of biomedical solutions worldwide, has signed a Letter of Intent with the Translational Health Science and Technology Institute (THSTI) in New Delhi, an autonomous institute under the Department of...
Lupin, a global pharmaceutical company, announced a licensing and supply agreement with Huons, a top Korean pharmaceutical company to enhance their ophthalmology offerings. The focus of the agreement is on registering and marketing Cyclosporine...
, CDSCO.jpg)
